Introduction
============

Heart rate has served as a marker for health and disease in humans for centuries. Prospective cohort studies and retrospective observational studies over the past several decades have contributed to a growing evidence base supporting an association between increased resting heart rate and adverse all‐cause and cardiovascular outcomes.^[@b1]--[@b2]^ Recent randomized clinical trial data from patients with heart failure (HF) have implicated heart rate as a potentially modifiable risk factor.^[@b3]--[@b4]^ Most of these prior studies examined patients with chronic stable HF and reduced ejection fraction (EF) participating in a clinical trial.^[@b4]--[@b10]^ The prognostic importance of discharge heart rate in unselected patients after hospitalization for HF has been less well studied. Few studies have included HF patients with preserved EF or those with atrial fibrillation (AF), or had sufficient power to evaluate potential time‐dependent differences in the relationship between heart rate and outcomes.

Given this growing awareness as well as potential therapeutic import of an association between resting heart rate and outcomes in patients with HF,^[@b11]^ we analyzed the relationship between heart rate at the time of hospital discharge and mortality and rehospitalization through 1 year in patients hospitalized for HF. We included patients in sinus rhythm (SR) as well as those in AF given the prevalence and prognostic importance of the latter in patients with HF.^[@b12]--[@b13]^ Our specific objectives were to (1) examine baseline patient characteristics across the distribution of heart rates recorded at discharge in hospitalized patients with a primary discharge diagnosis of HF; (2) examine the association between discharge heart rate and all‐cause mortality through 1 year in patients with SR and AF; and (3) examine the association between discharge heart rate and all‐cause hospital readmission and the composite outcome of all‐cause mortality or all‐cause readmission through 1 year in patients with SR and AF.

Methods
=======

Data Sources
------------

The Get With The Guidelines^®^--Heart Failure (GWTG‐HF) program is among the largest quality‐improvement initiatives focusing on patients hospitalized with clinician‐confirmed HF.^[@b14]^ The design of the program has been previously described.^[@b15]--[@b16]^ Hospitals participating in the registry use a web‐based patient management tool (PMT, Quintiles) to collect data for consecutive patients admitted with HF and to receive recommendations for qualitative improvement in medical management. Patients hospitalized with new or worsening HF as primary diagnosis or patients who developed significant HF symptoms such that HF was the primary discharge diagnosis were included in the registry starting January 1, 2005. Patients were enrolled into the program regardless of their left ventricular function. Hospitals from all regions of the United States are represented and a variety of institutions participate, from community hospitals to large tertiary medical centers. Data collected for each HF patient include demographics, medical/surgical history including any history of AF, admission medications, admission and discharge vital signs, physical examination, rhythm at time of admission, serum laboratory tests, pharmacological and nonpharmacologic interventions, in‐hospital outcomes, and discharge information. Trained hospital personnel enter the data by using standardized definitions. All participating hospitals were required to submit the GWTG‐HF protocol to their institutional review board for approval. Because data collected were used for qualitative performance improvement, sites were granted a waiver of informed consent under the common rule. Quintiles is the data collection coordination center for the American Heart Association/American Stroke Association Get With the Guidelines^®^ programs. The Duke Clinical Research Institute serves as the data analysis center and has an agreement to analyze de‐identified data for research purposes.

We obtained clinical data from the GWTG‐HF registry and Medicare claims data from the Centers for Medicare and Medicaid Services. The Medicare data include inpatient claims and corresponding denominator files for 2006 through 2011. The inpatient files contain hospitalization claims covered under Medicare Part A. The denominator files include date of death and information about program eligibility and enrollment. We linked data from the GWTG‐HF registry to the research identifiable inpatient claims data with the use of indirect identifiers: admission date, discharge date, sex, and age or date of birth.^[@b17]^ Combinations of these identifiers are almost always unique, enabling identification of registry hospitalizations in the Medicare claims data. For patients with multiple linked hospitalizations in the registry, we selected the first hospitalization for analysis.

Study Population
----------------

### SR group

From January 1, 2005, to December 31, 2011, there were 65 032 admissions for patients ≥65 years of age with HF, at 292 sites fully participating in GWTG‐HF. From these, we excluded (1) 2473 (3.8%) patients who were not enrolled in fee‐for‐service Medicare; (2) 2685 (4.1%) patients with missing EF information; and (3) 13 657 (21%) patients without discharge heart rate recorded. Finally, 20 197 patients without AF (defined as fitting none of the criteria for AF, ie, history of AF, AF at presentation or during hospitalization, or new‐onset of AF) comprised the SR group. The final sample size for the SR group was 26 020 patients from 271 sites.

### AF group

Above exclusions 1 to 3 were employed along with the exclusion of the 26 020 SR patients. The final sample size for the AF group was 20 197 patients from 262 sites.

### Outcome measures

The primary outcome was all‐cause mortality rate by 1 year. Secondary outcomes were all‐cause readmission rate by 1 year and all‐cause readmission or mortality rate by 1 year.

### Heart rate and rhythm determination

Heart rhythm was electrocardiographically determined. Heart rate was determined in conformance with local protocol for obtaining vital signs. For SR patients, heart rate was determined by palpation or telemetry (depending on patient location). For AF patients, heart rate was electrocardiographically or telemetrically determined.

### EF determination

EF in GWTG‐HF patients is determined by 2‐dimensional transthoracic echocardiography, gated scintigraphy, or contrast left ventriculography.

Statistical Analysis
--------------------

Baseline patient characteristics were compared across heart rate tertiles for SR and AF patients. Medians and (25th to 75th) percentiles were determined for continuous variables and percentages for categorical variables. Chi‐square tests were used to compare categorical variables across tertiles and Wilcoxon rank‐sum statistics were used to compare continuous variables across tertiles. Kaplan--Meier survival estimates are plotted by tertile and log rank statistics assessed the difference in survival across the tertiles.

We fit models separately in SR and AF patients to allow for different relationships between patient and hospital characteristics and outcome(s) in each subgroup. The association of heart rate with each outcome for SR patients was assessed using unadjusted and adjusted Cox proportional‐hazards regression models for 1‐year follow‐up. The functional form of heart rate was assessed by first comparing a linear fit to the fit of a restricted cubic spline. Evidence of a nonlinear relationship was identified and linear splines with and without truncation were considered. Several knot points were assessed, and the final transformation selected was the one that maximized model likelihood. The final linear spline was compared to the restricted cubic spline and suggested no lack of fit. Proportional hazards assumptions were assessed using Schoenfeld residuals. There was evidence of a nonproportional relationship over 1 year for each end point, but only for the upper portion of the linear spline (heart rate ≥75 beats per minute \[bpm\]). Subsequently, we determined that fitting a time‐varying hazard held proportional on the interval 0 to 30 days and from 31 to 365 days fit the data well. Although risk does not change suddenly at any 1 point in time, this approach attempts to compromise between model fit and intuitive interpretation. A model assuming proportional hazards throughout 1‐year follow‐up is also reported. Adjusted models include age, gender, race (white versus other), insurance (none, Medicare, Medicaid, other), EF, history of atrial flutter, history of chronic obstructive pulmonary disease (COPD) or asthma, history of diabetes, history of hypertension, history of hyperlipidemia, history of peripheral vascular disease, prior myocardial infarction, prior stroke or transient ischemic attack, history of anemia, history of chronic renal insufficiency, smoking, US census‐based geographic region, academic or teaching hospital, rural location, hospital size, and defect‐free compliance score (defined as the frequency of patients with 100% compliance with all GWTG‐HF‐defined performance measures). Single imputation was used to reduce missingness in models. Missing values for categorical variables were imputed to the most likely category.

To determine whether cardiac resynchronization therapy (CRT) might serve as an effect modifier of the heart‐rate‐outcome relationship, an interaction term was included in adjusted models. The analysis plan specified that if significant, the relationship between heart rate and outcome would be described within CRT and no CRT subgroups; if not significant, the interaction term was dropped and the model was simply adjusted for CRT. Effect modification by EF group (EF≤0.4 versus EF\>0.4) was explored in a similar manner.

A sensitivity analysis was performed to determine whether the association between heart rate and the primary outcome (all‐cause mortality at 1 year) might be biased by missing EF data. An indicator variable was defined reflecting the presence or absence of EF in each subject and an interaction term, heart rate×EF missing status, was added to the model and a formal test for interaction was performed.

The analysis was repeated in similar fashion for AF patients. A 2‐sided *P* value of \<0.05 was considered statistically significant for each test. Analyses were performed using SAS software (version 9.3; SAS Institute, Cary, NC).

Results
=======

Overall Sample
--------------

The overall sample ([Table 1](#tbl01){ref-type="table"}) comprised 46 217 patients from 273 sites with a primary discharge diagnosis of HF. The median (interquartile range) age was 80 (12) years with a slight female preponderance (54.3% female versus 45.7% male). Fifty‐four percent had a past medical history of HF. Discharge heart rate, the primary variable of interest, appeared normally distributed. The difference between discharge and admission heart rates was statistically significant (mean \[SD\] difference, −8.8 \[20\]; *P*\<0.0001). Vital signs at discharge, medications at discharge, and hospital characteristics are reported in Table S1.

###### 

Baseline Patient Characteristics, Overall and by Heart Rate Tertiles

  Variable                                      Level                    Overall (N=46 217)   T1 (32 to 68 bpm) (N=16 273)   T2 (69 to 79 bpm) (N=14 574)   T3 (80 to 168 bpm) (N=15 370)   *P* Value                             
  --------------------------------------------- ------------------------ -------------------- ------------------------------ ------------------------------ ------------------------------- ----------- -------- -------- ------- ----------
  Demographics                                                                                                                                                                                                                    
  Age                                           Median                   46 217               80                             16 273                         81                              14 574      81       15 370   80      \<0.0001
  25^th^                                                                 74                                                  74                                                             74                   73               
  75^th^                                                                 86                                                  86                                                             86                   86               
  Gender                                        Female                   25 088               54.3                           8816                           54.2                            7734        53.1     8538     55.5    \<0.0001
  Male                                          21 129                   45.7                 7457                           45.8                           6840                            46.9        6832     44.4             
  Race                                          Other (includes UTD)     1062                 2.3                            385                            2.4                             332         2.3      345      2.3     0.0761
  Asian                                         582                      1.3                  234                            1.4                            183                             1.3         165      1.1              
  Hispanic (any race)                           2211                     4.8                  803                            4.9                            704                             4.9         704      4.6              
  Black                                         4474                     9.8                  1562                           9.7                            1374                            9.5         1538     10.1             
  White                                         37 478                   81.8                 13 141                         81.5                           11 867                          82.1        12 470   81.9             
  Missing                                       410                      0.9                  148                            0.9                            114                             0.8         148      0.9              
  Medical history                                                                                                                                                                                                                 
  Chronic or recurrent atrial fib               Yes                      17 277               37.7                           5749                           35.6                            5474        37.9     6054     39.7    \<0.0001
  Atrial flutter                                Yes                      1020                 2.2                            370                            2.3                             302         2.1      348      2.3     0.4140
  COPD or asthma                                Yes                      13 223               28.8                           4174                           25.8                            4065        28.1     4984     32.7    \<0.0001
  Diabetes---insulin treated                    Yes                      7632                 16.6                           2858                           17.7                            2425        16.8     2349     15.4    \<0.0001
  Diabetes---noninsulin treated                 Yes                      10 775               23.5                           3869                           23.9                            3401        23.5     3505     22.9    0.1267
  Hyperlipidemia                                Yes                      21 761               47.5                           8160                           50.5                            6833        47.3     6768     44.4    \<0.0001
  Hypertension                                  Yes                      35 584               77.6                           12 908                         79.9                            11 197      77.5     11 479   75.3    \<0.0001
  PVD                                           Yes                      6490                 14.1                           2403                           14.9                            2021        13.9     2066     13.5    0.0026
  CAD                                           Yes                      23 915               52.2                           8921                           55.2                            7719        53.4     7275     47.7    \<0.0001
  Prior MI                                      Yes                      8463                 18.5                           3185                           19.7                            2727        18.9     2551     16.7    \<0.0001
  CVA/TIA                                       Yes                      7590                 16.5                           2809                           17.4                            2409        16.7     2372     15.6    \<0.0001
  ICD                                           Yes                      3407                 7.4                            1212                           7.5                             1231        8.5      964      6.3     \<0.0001
  Heart failure                                 Yes                      24 717               53.9                           8755                           54.2                            7807        54.0     8155     53.5    0.4049
  Anemia                                        Yes                      9043                 19.7                           3231                           20.0                            2844        19.7     2968     19.5    0.4767
  Pacemaker                                     Yes                      6552                 14.3                           2406                           14.9                            2408        16.7     1738     11.4    \<0.0001
  CRT‐P (CRT‐pacing only)                       Yes                      323                  0.7                            126                            0.8                             107         0.7      90       0.6     0.1087
  CRT‐D (CRT with ICD)                          Yes                      885                  1.9                            277                            1.7                             365         2.5      243      1.6     \<0.0001
  Dialysis (chronic)                            Yes                      1319                 2.9                            402                            2.5                             388         2.7      529      3.5     \<0.0001
  Renal insufficiency                           Yes                      8927                 19.5                           3356                           20.8                            2779        19.2     2792     18.3    \<0.0001
  Depression                                    Yes                      4711                 10.3                           1627                           10.1                            1489        10.3     1595     10.5    0.5264
  Prior PCI                                     Yes                      4679                 10.2                           1770                           10.9                            1523        10.5     1386     9.1     \<0.0001
  Prior CABG                                    Yes                      6787                 14.8                           2620                           16.2                            2194        15.2     1973     12.9    \<0.0001
  Valvular heart disease                        Yes                      6692                 14.6                           2314                           14.3                            2102        14.5     2276     14.9    0.3188
  CABG/PCI undetermined                         Yes                      6108                 13.3                           2261                           14.0                            2032        14.1     1815     11.9    \<0.0001
  Smoking                                       Yes                      4188                 9.1                            1353                           8.4                             1271        8.8      1564     10.3    \<0.0001
  Diagnosis                                                                                                                                                                                                                       
  Cardiac diagnosis                             Heart failure with CAD   20 740               44.96                          7734                           47.60                           6681        45.93    6325     41.23   \<0.0001
  Confirmed AMI---non‐STEMI                     113                      0.24                 42                             0.26                           33                              0.23        38       0.25             
  Confirmed AMI---STEMI                         10                       0.02                 1                              0.01                           3                               0.02        6        0.04             
  Confirmed AMI---STEMI/non‐STEMI unspecified   13                       0.03                 3                              0.02                           7                               0.05        3        0.02             
  Other                                         670                      1.45                 242                            1.49                           188                             1.29        240      1.56             
  Peripheral vascular disease                   38                       0.08                 15                             0.09                           10                              0.07        13       0.08             
  Cerebral vascular disease                     9                        0.02                 2                              0.01                           4                               0.03        3        0.02             
  Unstable angina                               52                       0.11                 23                             0.14                           6                               0.04        23       0.15             
  Coronary artery disease                       90                       0.20                 31                             0.19                           22                              0.15        37       0.24             
  Heart failure, no CAD                         24 398                   52.89                8156                           50.19                          7591                            52.19       8651     56.40            
  Missing                                       84                       0.18                 24                             0.15                           29                              0.20        31       0.20             
  Vital signs at admission                                                                                                                                                                                                        
  Heart rate, bpm                               Median                   45 668               80                             16 050                         72                              14 417      80       15 201   89      \<0.0001
  25^th^                                                                 69                                                  63                                                             70                   78               
  75^th^                                                                 94                                                  85                                                             92                   103              
  Systolic blood pressure, mm Hg                Median                   45 664               139                            16 059                         143                             14 409      139      15 196   134     \<0.0001
  25^th^                                                                 120                                                 124                                                            120                  117              
  75^th^                                                                 159                                                 164                                                            159                  153              
  Diastolic blood pressure, mm Hg               Median                   45 692               73                             16 072                         72                              14 416      73       15 204   74      \<0.0001
  25^th^                                                                 63                                                  62                                                             63                   64               
  75^th^                                                                 85                                                  84                                                             85                   85               
  Labs at admission                                                                                                                                                                                                               
  BNP \<100                                     Yes                      2002                 5.9                            653                            5.5                             588         5.5      761      6.8     \<0.0001
  No                                            31 670                   94.1                 11 237                         94.5                           10 018                          94.5        10 415   93.2             
  Missing                                       12 545                   27.1                 4383                           26.9                           3968                            27.2        4194     27.3             
  Serum creatinine, mg/dL                       Median                   41 899               1.3                            14 667                         1.3                             13 229      1.3      14 003   1.3     \<0.0001
  25^th^                                                                 1.0                                                 1.0                                                            1.0                  1.0              
  75^th^                                                                 1.8                                                 1.8                                                            1.8                  1.8              
  BUN, mg/dL                                    Median                   41 563               25                             14 564                         26                              13 120      25       13 879   25      \<0.0001
  25^th^                                                                 18                                                  18                                                             18                   18               
  75^th^                                                                 37                                                  37                                                             37                   37               
  Troponin, ng/dL                               Median                   34 666               0.05                           12 262                         0.05                            10 875      0.05     11 529   0.05    0.0731
  25^th^                                                                 0.03                                                0.03                                                           0.03                 0.03             
  75^th^                                                                 0.10                                                0.10                                                           0.10                 0.11             
  Ejection fraction                             Median                   46 217               45                             16 273                         50                              14 574      45       15 370   45      \<0.0001
  25^th^                                                                 30                                                  30                                                             30                   30               
  75^th^                                                                 55                                                  57                                                             55                   55               

AMI indicates acute myocardial infarction; BNP, brain natriuretic peptide; BUN, blood urea nitrogen; CABG, coronary artery bypass graft; CAD indicates coronary artery disease; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CVA/TIA, cerebrovascular accident/transient ischemic attack; ICD, implantable cardiac defibrillator; MI, myocardial infarction; PCI, percutaneous coronary intervention; PVD, peripheral vascular disease; STEMI, ST‐segment elevation myocardial infarction; UTD, unable to determine.

SR Patients
-----------

There were 26 020 HF patients in the SR group. Discharge heart rates appeared normally distributed with a median of 72 bpm and interquartile range of 18 bpm.

Characteristics of SR Patients
------------------------------

Younger patients, women, and nonwhite patients were more likely to have a higher heart rate ([Table 2](#tbl02){ref-type="table"}). A higher heart rate and lower systolic blood pressure on both admission and discharge were more frequent in the highest discharge heart rate tertile. Patients with higher discharge heart rate were more likely to have a history of COPD and smoking but less likely to have a history of diabetes, hypertension, peripheral vascular disease, prior myocardial infarction, prior stroke, and renal insufficiency. For SR patients with a history of COPD or asthma, and eligible for β‐blocker therapy, 91.6% were prescribed β‐blockers at discharge and 8.4% were not. For patients with a history of COPD or asthma, and eligible for evidence‐based β‐blocker therapy, 80.5% were prescribed evidence‐based β‐blockers at discharge and 19.5% were not. The quality of care composite measure, defect‐free care, was lowest in the highest heart rate tertile. Importantly, this measure includes the use of β‐blockers. Vital signs at discharge, medications at discharge, and hospital characteristics are reported in Table S2.

###### 

Baseline Patient Characteristics for Patients With Normal Sinus Rhythm, Overall and by Heart Rate Tertiles

  Variable                                      Level                    Overall (N=26 020)   T1 (33 to 67 bpm) (N=8544)   T2 (68 to 78 bpm) (N=8793)   T3 (79 to 148 bpm) (N=8683)   *P* Value                           
  --------------------------------------------- ------------------------ -------------------- ---------------------------- ---------------------------- ----------------------------- ----------- ------- ------- ------- ----------
  Demographics                                                                                                                                                                                                            
  Age                                           Median                   26 020               79                           8544                         80                            8793        79      8683    79      \<0.0001
  25th                                                                   72                                                73                                                         73                  72              
  75th                                                                   85                                                86                                                         85                  85              
  Gender                                        Female                   14 448               55.5                         4763                         55.7                          4806        54.7    4879    56.2    0.1104
  Male                                          11 572                   44.5                 3781                         44.2                         3987                          45.3        3804    43.8            
  Race                                          White                    19 799               76.9                         6531                         77.2                          6689        76.8    6579    76.5    0.0011
  Black                                         3326                     12.9                 1024                         12.1                         1103                          12.7        1199    13.9            
  Hispanic (any race)                           1586                     6.2                  534                          6.3                          567                           6.5         485     5.6             
  Asian                                         366                      1.4                  135                          1.6                          132                           1.5         99      1.15            
  Other (includes UTD)                          682                      2.6                  232                          2.7                          217                           2.5         233     2.71            
  Missing                                       261                      1.0                  88                           1.0                          85                            1.0         88      1.0             
  Medical history                                                                                                                                                                                                         
  Chronic or recurrent atrial fib               No                       25 667               100                          8435                         100                           8671        100     8561    100     
  Atrial flutter                                Yes                      325                  1.3                          113                          1.3                           105         1.2     107     1.2     0.7430
  COPD or asthma                                Yes                      7262                 28.3                         2105                         24.9                          2327        26.8    2830    33.1    \<0.0001
  Diabetes---insulin treated                    Yes                      4770                 18.6                         1690                         20.0                          1624        18.7    1456    17.0    \<0.0001
  Diabetes---non‐insulin‐treated                Yes                      6446                 25.1                         2118                         25.1                          2196        25.3    2132    24.9    0.8153
  Hyperlipidemia                                Yes                      12 284               47.9                         4282                         50.8                          4221        48.7    3781    44.2    \<0.0001
  Hypertension                                  Yes                      20 076               78.2                         6813                         80.8                          6829        78.8    6434    75.2    \<0.0001
  PVD                                           Yes                      3692                 14.4                         1254                         14.9                          1276        14.7    1162    13.6    0.0311
  CAD                                           Yes                      13 628               53.1                         4759                         56.4                          4729        54.5    4140    48.4    \<0.0001
  Prior MI                                      Yes                      4902                 19.1                         1759                         20.8                          1706        19.7    1437    16.8    \<0.0001
  CVA/TIA                                       Yes                      3973                 15.5                         1390                         16.5                          1378        15.9    1205    14.1    \<0.0001
  ICD                                           Yes                      1770                 6.9                          574                          6.8                           663         7.7     533     6.2     0.0011
  Heart failure                                 Yes                      12 722               49.6                         4242                         50.3                          4327        49.9    4153    48.5    0.0504
  Anemia                                        Yes                      5011                 19.5                         1674                         19.8                          1687        19.5    1650    19.3    0.6300
  Pacemaker                                     Yes                      2786                 10.8                         980                          11.6                          1063        12.3    743     8.7     \<0.0001
  CRT‐P (CRT‐pacing only)                       Yes                      94                   0.4                          36                           0.4                           31          0.4     27      0.3     0.4789
  CRT‐D (CRT with ICD)                          Yes                      435                  1.7                          137                          1.6                           183         2.1     115     1.3     0.0004
  Dialysis (chronic)                            Yes                      940                  3.7                          266                          3.1                           286         3.3     388     4.5     \<0.0001
  Renal insufficiency                           Yes                      5245                 20.4                         1810                         21.5                          1775        20.5    1660    19.4    0.0037
  Depression                                    Yes                      2594                 10.1                         815                          9.7                           905         10.4    874     10.2    0.2259
  Prior PCI                                     Yes                      2711                 10.6                         939                          11.1                          975         11.2    797     9.3     \<0.0001
  Prior CABG                                    Yes                      3564                 13.9                         1329                         15.8                          1216        14.0    1019    11.9    \<0.0001
  Valvular heart disease                        Yes                      2857                 11.1                         940                          11.1                          946         10.9    971     11.3    0.6651
  CABG/PCI undetermined                         Yes                      3745                 14.6                         1289                         15.3                          1366        15.7    1090    12.7    \<0.0001
  Smoking                                       Yes                      2751                 10.7                         816                          9.6                           894         10.3    1041    12.1    \<0.0001
  Diagnosis                                                                                                                                                                                                               
  Cardiac diagnosis                             Heart failure with CAD   11 556               44.50                        4050                         47.48                         4008        45.65   3498    40.39   \<0.0001
  Confirmed AMI---non‐STEMI                     81                       0.31                 24                           0.28                         29                            0.33        28      0.32            
  Confirmed AMI---STEMI                         8                        0.03                 1                            0.01                         2                             0.02        5       0.06            
  Confirmed AMI---STEMI/non‐STEMI unspecified   11                       0.04                 1                            0.01                         6                             0.07        4       0.05            
  Other                                         432                      1.66                 140                          1.64                         136                           1.55        156     1.80            
  Peripheral vascular disease                   24                       0.09                 7                            0.08                         10                            0.11        7       0.08            
  Cerebral vascular disease                     6                        0.02                 2                            0.02                         2                             0.02        2       0.02            
  Unstable angina                               35                       0.13                 18                           0.21                         3                             0.03        14      0.16            
  Coronary artery disease                       58                       0.22                 23                           0.27                         14                            0.16        21      0.24            
  Heart failure, no CAD                         13 759                   52.98                4264                         49.99                        4569                          52.04       4926    56.88           
  Missing                                       50                       0.19                 14                           0.16                         14                            0.16        22      0.25            
  Vital signs at admission                                                                                                                                                                                                
  Heart rate, bpm                               Median                   25 681               80                           8426                         71                            8687        80      8568    88      \<0.0001
  25th                                                                   69                                                62                                                         70                  78              
  75th                                                                   93                                                84                                                         91                  101             
  Systolic blood pressure, mm Hg                Median                   25 666               142                          8419                         147                           8680        141     8567    137     \<0.0001
  25th                                                                   122                                               127                                                        123                 118             
  75th                                                                   163                                               169                                                        163                 157             
  Diastolic blood pressure, mm Hg               Median                   25 692               73                           8430                         72                            8688        73      8574    73      0.0069
  25th                                                                   63                                                62                                                         63                  63              
  75th                                                                   85                                                84                                                         85                  85              
  Labs at admission                                                                                                                                                                                                       
  BNP \<100 pg/mL                               Yes                      1183                 6.3                          316                          5.1                           404         6.4     463     7.4     \<0.0001
  No                                            17 626                   93.7                 5865                         94.9                         5951                          93.6        5810    92.6            
  Missing                                       7211                     27.7                 2363                         27.7                         2438                          27.7        2410    27.8            
  Serum creatinine, mg/dL                       Median                   23 562               1.3                          7671                         1.4                           7972        1.3     7919    1.3     \<0.0001
  25th                                                                   1.0                                               1.0                                                        1.0                 1.0             
  75th                                                                   1.8                                               1.9                                                        1.8                 1.8             
  BUN, mg/dL                                    Median                   23 352               25                           7613                         26                            7903        25      7836    25      \<0.0001
  25th                                                                   18                                                18                                                         18                  17              
  75th                                                                   37                                                37                                                         37                  37              
  Troponin, ng/dL                               Median                   19 600               0.05                         6454                         0.05                          6595        0.05    6551    0.06    \<0.0001
  25th                                                                   0.03                                              0.03                                                       0.03                0.03            
  75th                                                                   0.12                                              0.10                                                       0.12                0.13            
  Ejection fraction                             Median                   26 020               45                           8544                         50                            8793        45      8683    40      \<0.0001
  25th                                                                   30                                                30                                                         30                  26              
  75th                                                                   55                                                58                                                         55                  55              

AMI indicates acute myocardial infarction; BNP, brain natriuretic peptide; bpm, beats per minute; BUN, blood urea nitrogen; CABG, coronary artery bypass graft; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CVA/TIA, cerebrovascular accident/transient ischemic attack; ICD, implantable cardiac defibrillator; MI, myocardial infarction; PCI, percutaneous coronary intervention; PVD, peripheral vascular disease; STEMI, ST‐segment elevation myocardial infarction; UTD, unable to determine.

Study Outcomes in SR Patients
-----------------------------

Overall all‐cause mortality at 1 year was 30.1%, and the rate of all‐cause readmission or mortality at 1 year was 70.0% ([Table 3](#tbl03){ref-type="table"}). There were significant differences in each outcome by 1 year across the discharge heart rate tertiles, with higher mortality and the composite outcome of mortality or all‐cause readmission in the highest tertile ([Table 3](#tbl03){ref-type="table"}). Survival by 1 year was significantly different across the tertiles, with the lowest survival rate occurring in the highest tertile (log rank *P*\<0.0001) ([Figure 1](#fig01){ref-type="fig"}). A similar pattern was observed for the composite outcome of readmission/mortality by 1 year.

###### 

Frequency of 1‐Year Outcomes by Heart Rate Tertiles (Sinus Rhythm Patients)

  Variable                             Level   Overall (N=26 020)   T1 (33 to 67 bpm) (N=8544)   T2 (68 to 78 bpm) (N=8793)   T3 (79 to 148 bpm) (N=8683)   *P* Value                          
  ------------------------------------ ------- -------------------- ---------------------------- ---------------------------- ----------------------------- ----------- ------- ------ ------- ----------
  Mortality                            Yes     7820                 30.05                        2283                         26.72                         2512        28.57   3025   34.84   \<0.0001
  All‐cause readmission                Yes     16 154               62.09                        5277                         61.76                         5500        62.56   5377   61.93   0.5236
  Mortality or all‐cause readmission   Yes     18 219               70.02                        5835                         68.29                         6116        69.56   6268   72.20   \<0.0001

![Kaplan--Meier plot of event‐free survival by 1 year in patients with sinus rhythm (n=26 020). There was a significant difference across the discharge heart rate tertiles (log rank *P*\<0.0001) with survival highest in the lowest tertile (see text for details). BPM indicates beats per minute.](jah3-4-e001626-g1){#fig01}

Crude and adjusted measures of the association between discharge heart rate (expressed as a continuous variable) and each outcome are reported in [Table 4](#tbl04){ref-type="table"}. For patients with a discharge heart rate ≥75 bpm, there were worse outcomes with increasing heart rate. The slope of this relationship changed for patients with heart rate \<75 bpm ([Figure 2](#fig02){ref-type="fig"}). After adjustment for differences in clinical characteristics, the risk for all‐cause mortality at heart rate \<75 increased by 6.0% (hazard ratio \[HR\] 1.060, 95% CI 1.018, 1.103; *P*=0.0047) per 10‐bpm increment over the 1 year of follow‐up. At heart rate ≥75 bpm, the risk for all‐cause mortality increased by 18.5% (HR 1.185, 95% CI 1.149, 1.222; *P*\<0.0001) per 10‐bpm increment over the 1 year of follow‐up. When the data were analyzed by time interval to better meet proportionality assumptions, there was a 19.2% higher risk for mortality (HR 1.192, 95% CI 1.075, 1.322; *P*=0.0008) per 10‐bpm increment in heart rate \<75 bpm over the first 30 days. There was a 30.0% higher risk for mortality (HR 1.300, 95% CI 1.219, 1.386; *P*\<0.0001) per 10‐bpm increment in heart rate ≥75 bpm over the first 30 days. Beyond that and through 365 days, the risk for all‐cause mortality was not significant for heart rates \<75 bpm but was 15.5% higher (HR 1.155, 95% CI 1.116, 1.196; *P*\<0.0001) per 10‐bpm increase in heart rate ≥75 bpm. Qualitatively similar patterns were observed for the association between discharge heart rate and all‐cause readmission as well as the composite of all‐cause mortality or readmission ([Table 4](#tbl04){ref-type="table"}). For all outcomes, the HR over the first 30 days was significantly different from 1.0 at heart rates \<75 bpm but was not significantly different from 1.0 over the interval from 31 to 365 days.

###### 

Hazard Ratios (HR) for Heart Rate per 10 bpm (Sinus Rhythm Patients, n=26 020)

  Outcome                                                Unadjusted Model   Adjusted Model (Patient and Hospital Characteristics)                                     
  ------------------------------------------------------ ------------------ ------------------------------------------------------- ---------- ------- -------------- ----------
  Mortality                                                                                                                                                           
  Heart rate \<75 bpm[\*](#tf4-1){ref-type="table-fn"}   1.054              1.015, 1.094                                            0.0061     1.060   1.018, 1.103   0.0047
  Heart rate \<75 bpm                                                                                                                                                 
  \[0, 30\] days                                         1.125              1.034, 1.224                                            0.0061     1.192   1.075, 1.322   0.0008
  \[31, 365\] days                                       1.045              1.002, 1.089                                            0.0417     1.040   0.995, 1.086   0.0794
  Heart rate ≥75 bpm[\*](#tf4-1){ref-type="table-fn"}    1.211              1.179, 1.245                                            \<0.0001   1.185   1.149, 1.222   \<0.0001
  Heart rate ≥75 bpm                                                                                                                                                  
  \[0, 30\] days                                         1.385              1.320, 1.454                                            \<0.0001   1.300   1.219, 1.386   \<0.0001
  \[31, 365\] days                                       1.146              1.109, 1.184                                            \<0.0001   1.155   1.116, 1.196   \<0.0001
  All‐cause readmission                                                                                                                                               
  Heart rate \<75 bpm[\*](#tf4-1){ref-type="table-fn"}   1.025              1.000, 1.052                                            0.0514     1.019   0.993, 1.046   0.1519
  Heart rate \<75 bpm                                                                                                                                                 
  \[0, 30\] days                                         1.056              1.011, 1.102                                            0.0141     1.045   0.999, 1.092   0.0530
  \[31, 365\] days                                       1.013              0.982, 1.045                                            0.4309     1.009   0.977, 1.042   0.5787
  Heart rate ≥75 bpm[\*](#tf4-1){ref-type="table-fn"}    1.054              1.031, 1.077                                            \<0.0001   1.063   1.039, 1.088   \<0.0001
  Heart rate ≥75 bpm                                                                                                                                                  
  \[0, 30\] days                                         1.104              1.067, 1.142                                            \<0.0001   1.128   1.089, 1.168   \<0.0001
  \[31, 365\] days                                       1.020              0.991, 1.050                                            0.1777     1.020   0.990, 1.051   0.1872
  Composite readmission/mortality                                                                                                                                     
  Heart rate \<75 bpm[\*](#tf4-1){ref-type="table-fn"}   1.024              1.000, 1.049                                            0.0541     1.023   0.998, 1.049   0.0769
  Heart rate \<75 bpm                                                                                                                                                 
  \[0, 30\] days                                         1.051              1.010, 1.094                                            0.0148     1.052   1.008, 1.097   0.0191
  \[31, 365\] days                                       1.014              0.984, 1.044                                            0.3771     1.011   0.980, 1.042   0.4931
  Heart rate ≥75 bpm[\*](#tf4-1){ref-type="table-fn"}    1.098              1.077, 1.120                                            \<0.0001   1.082   1.059, 1.105   \<0.0001
  Heart rate ≥75 bpm                                                                                                                                                  
  \[0, 30\] days                                         1.171              1.137, 1.206                                            \<0.0001   1.148   1.111, 1.186   \<0.0001
  \[31, 365\] days                                       1.044              1.016, 1.072                                            0.0018     1.037   1.008, 1.067   0.0125

Ignoring violation of proportional hazards assumption (see text for details), model adjusted for the following covariates: age, gender, race (white vs other), insurance (none, Medicare, Medicaid, other), ejection fraction, history of atrial flutter, history of chronic obstructive pulmonary disease or asthma, history of diabetes, history of hyperlipidemia, history of hypertension, history of peripheral vascular disease, prior myocardial infarction, prior stroke or transient ischemic attack, history of anemia, history of chronic renal insufficiency, pacemaker, smoking, geographic region, academic or teaching hospital, rural location, hospital size, and defect‐free compliance score.

![Estimated mortality at 1 year in patients with sinus rhythm (n=26 020). The inflection point represents a single linear spline at 75 bpm (see text for details). Risk of mortality rises steadily with heart rate. BPM indicates beats per minute.](jah3-4-e001626-g2){#fig02}

There was no evidence for effect modification by CRT in models for mortality (interaction *P*=0.374), all‐cause readmission (*P*=0.952), or composite readmission/mortality (*P*=0.981). Including CRT in the adjusted model did not meaningfully change the HRs or 95% CIs for all‐cause mortality or all‐cause readmission at heart rate ≥75 bpm at either 0 to 30 days or 31 to 365 days. However, the HRs for heart rate \<75 bpm at 0 to 30 days and heart rate ≥75 bpm at 31 to 365 days were no longer significant for the composite of all‐cause mortality/readmission. There was no evidence of effect modification by EF in adjusted models for mortality (interaction *P*=0.292), all‐ cause readmission (*P*=0.054), or composite readmission/mortality (*P*=0.187).

EF data were missing in 6.06% of SR patients. There was no significant interaction between heart rate and the presence or absence of missing EF data (*P* for interaction 0.87), indicating no difference in the degree of association between heart rate and all‐cause mortality between those with missing and nonmissing EF data.

AF Patients
-----------

There were 20 197 patients (43.7%) with either a history of AF or AF documented during the index hospitalization. Similar to the SR patients, discharge heart rates appeared normally distributed with a median of 74 bpm and interquartile range of 19 bpm.

Characteristics of AF Patients
------------------------------

Women and white patients were more likely to have higher heart rate ([Table 5](#tbl05){ref-type="table"}). A higher heart rate and lower systolic blood pressure on both admission and discharge were more frequent in the highest discharge heart rate tertile. Patients with higher discharge heart rates were more likely to have a history of COPD and smoking but less likely to have a history of diabetes, hypertension, peripheral vascular disease, prior myocardial infarction, prior stroke, and renal insufficiency. EF significantly varied by discharge heart rate tertile. For AF patients with a history of COPD or asthma, and eligible for β‐blocker therapy, 91.4% were prescribed β‐blockers at discharge, and 8.7% were not. For patients with a history of COPD or asthma, and eligible for evidence‐based β‐blockers, 78.8% were prescribed evidence‐based β‐blockers at discharge, and 21.2% were not. Defect‐free care was lowest in the highest discharge heart rate tertile. Importantly, this measure includes the use of β‐blockers. Vital signs at discharge, medications at discharge, and hospital characteristics are reported in Table S3.

###### 

Baseline Patient Characteristics for Patients With Atrial Fibrillation, Overall and by Heart Rate Tertiles

  Variable                                      Level                    Overall (N=20 197)   T1 (32 to 68 bpm) (N=6692)   T2 (69 to 79 bpm) (N=6385)   T3 (80 to 168 bpm) (N=7120)   *P* Value                           
  --------------------------------------------- ------------------------ -------------------- ---------------------------- ---------------------------- ----------------------------- ----------- ------- ------- ------- ----------
  Demographics                                                                                                                                                                                                            
  Age                                           Median                   20 197               82                           6692                         82                            6385        82      7120    81      0.0591
  25^th^                                                                 75                                                75                                                         76                  75              
  75^th^                                                                 87                                                87                                                         87                  87              
  Gender                                        Female                   10 640               52.7                         3480                         52.0                          3264        51.1    3896    54.7    \<0.0001
  Male                                          9557                     47.3                 3212                         48.0                         3121                          48.9        3224    45.3            
  Race                                          White                    17 679               88.2                         5835                         87.8                          5642        88.9    6202    87.9    0.0489
  Black                                         1148                     5.7                  409                          6.2                          329                           5.2         410     5.8             
  Hispanic (any race)                           625                      3.1                  193                          2.9                          186                           2.9         246     3.5             
  Asian                                         216                      1.2                  86                           1.3                          60                            0.95        70      1.0             
  Other (includes UTD)                          380                      1.9                  123                          1.9                          126                           1.99        131     1.8             
  Missing                                       149                      0.7                  46                           0.7                          42                            0.66        61      0.9             
  Medical history                                                                                                                                                                                                         
  Chronic or recurrent atrial fib               Yes                      17 277               85.6                         5749                         85.9                          5474        85.8    6054    85.1    0.3493
  Atrial flutter                                Yes                      695                  3.4                          245                          3.7                           203         3.2     247     3.5     0.3191
  COPD or asthma                                Yes                      5961                 29.5                         1796                         26.8                          1888        29.6    2277    32.0    \<0.0001
  Diabetes---insulin treated                    Yes                      2862                 14.2                         964                          14.4                          926         14.5    972     13.7    0.2989
  Diabetes---non‐insulin‐treated                Yes                      4329                 21.5                         1481                         22.1                          1358        21.3    1490    20.9    0.2219
  Hyperlipidemia                                Yes                      9477                 46.9                         3368                         50.3                          2937        46.0    3172    44.6    \<0.0001
  Hypertension                                  Yes                      15 508               76.8                         5265                         78.7                          4879        76.5    5364    75.4    \<0.0001
  PVD                                           Yes                      2798                 13.9                         986                          14.7                          855         13.4    957     13.5    0.0410
  CAD                                           Yes                      10 287               51.0                         3598                         53.8                          3334        52.3    3355    47.2    \<0.0001
  Prior MI                                      Yes                      3561                 17.6                         1213                         18.1                          1158        18.1    1190    16.7    0.0431
  CVA/TIA                                       Yes                      3617                 17.9                         1252                         18.7                          1140        17.9    1225    17.2    0.0743
  ICD                                           Yes                      1637                 8.1                          569                          8.5                           607         9.5     461     6.5     \<0.0001
  Heart failure                                 Yes                      11 995               59.4                         3991                         59.6                          3797        59.5    4207    59.2    0.8272
  Anemia                                        Yes                      4032                 20.0                         1371                         20.5                          1254        19.7    1407    19.8    0.4329
  Pacemaker                                     Yes                      3766                 18.7                         1308                         19.5                          1423        22.3    1035    14.5    \<0.0001
  CRT‐P (CRT‐pacing only)                       Yes                      229                  1.1                          84                           1.3                           80          1.3     65      0.9     0.0921
  CRT‐D (CRT with ICD)                          Yes                      450                  2.2                          128                          1.9                           188         2.9     134     1.9     \<0.0001
  Dialysis (chronic)                            Yes                      379                  1.9                          113                          1.7                           110         1.7     156     2.2     0.0509
  Renal insufficiency                           Yes                      3682                 18.2                         1326                         19.8                          1135        17.8    1221    17.2    0.0002
  Depression                                    Yes                      2117                 10.5                         706                          10.5                          658         10.3    753     10.6    0.8577
  Prior PCI                                     Yes                      1968                 9.7                          716                          10.7                          612         9.6     640     9.0     0.0030
  Prior CABG                                    Yes                      3223                 16.0                         1159                         17.3                          1056        16.5    1008    14.2    \<0.0001
  Valvular heart disease                        Yes                      3835                 19.0                         1259                         18.8                          1206        18.9    1370    19.3    0.7774
  CABG/PCI undetermined                         Yes                      2363                 11.7                         823                          12.3                          769         12.1    771     10.8    0.0167
  Medical history                                                                                                                                                                                                         
  Smoking                                       Yes                      1437                 7.2                          421                          6.3                           445         7.0     571     8.1     0.0003
  Diagnosis                                                                                                                                                                                                               
  Cardiac diagnosis                             Heart failure with CAD   9184                 45.55                        3200                         47.89                         2983        46.81   3001    42.21   \<0.0001
  Confirmed AMI---non‐STEMI                     32                       0.16                 12                           0.18                         10                            0.16        10      0.14            
  Confirmed AMI---STEMI                         2                        0.01                 0                            0.00                         1                             0.02        1       0.01            
  Confirmed AMI---STEMI/non‐STEMI unspecified   2                        0.01                 2                            0.03                         0                             0.00        0       0.00            
  Other                                         238                      1.18                 80                           1.20                         67                            1.05        91      1.28            
  Peripheral vascular disease                   14                       0.07                 7                            0.10                         1                             0.02        6       0.08            
  Cerebral vascular disease                     3                        0.01                 0                            0.00                         2                             0.03        1       0.01            
  Unstable angina                               17                       0.08                 4                            0.06                         4                             0.06        9       0.13            
  Coronary artery disease                       32                       0.16                 7                            0.10                         9                             0.14        16      0.23            
  Heart failure, no CAD                         10 639                   52.76                3370                         50.43                        3295                          51.71       3974    55.90           
  Missing                                       34                       0.17                 10                           0.15                         13                            0.20        11      0.15            
  Vital signs at admission                                                                                                                                                                                                
  Heart rate, bpm                               Median                   19 987               81                           6601                         73                            6324        80      7062    90      \<0.0001
  25^th^                                                                 70                                                63                                                         70                  78              
  75^th^                                                                 97                                                87                                                         93                  105             
  Systolic blood pressure, mm Hg                Median                   19 998               135                          6615                         138                           6325        135     7058    132     \<0.0001
  25^th^                                                                 118                                               120                                                        118                 115             
  75^th^                                                                 154                                               158                                                        154                 150             
  Diastolic blood pressure, mm Hg               Median                   20 000               73                           6616                         72                            6326        73      7058    74      \<0.0001
  25th                                                                   63                                                62                                                         63                  64              
  75th                                                                   85                                                83                                                         84                  86              
  Labs at admission                                                                                                                                                                                                       
  BNP \<100 pg/mL                               Yes                      819                  5.5                          269                          5.4                           242         5.1     308     5.9     0.2406
  No                                            14 044                   94.5                 4690                         94.6                         4454                          94.8        4900    94.1            
  Missing                                       5334                     26.4                 1733                         25.9                         1689                          26.4        1912    26.8            
  Serum creatinine, mg/dL                       Median                   18 337               1.3                          6062                         1.3                           5795        1.3     6480    1.3     \<0.0001
  25^th^                                                                 1.0                                               1.0                                                        1.0                 1.0             
  75^th^                                                                 1.7                                               1.7                                                        1.7                 1.7             
  BUN, mg/dL                                    Median                   18 211               26                           6023                         26                            5750        26      6438    25      0.2853
  25^th^                                                                 18                                                18                                                         18                  18              
  75^th^                                                                 37                                                38                                                         37                  37              
  Troponin, ng/dL                               Median                   15 066               0.05                         5019                         0.05                          4737        0.05    5310    0.05    0.0117
  25^th^                                                                 0.03                                              0.03                                                       0.03                0.02            
  75^th^                                                                 0.10                                              0.10                                                       0.10                0.10            
  Ejection fraction                             Median                   20 197               48                           6692                         50                            6385        45      7120    48      \<0.0001
  25^th^                                                                 30                                                32                                                         30                  30              
  75^th^                                                                 55                                                57                                                         55                  55              

AMI indicates acute myocardial infarction; bpm, beats per minute; BNP, brain natriuretic peptide; BUN, blood urea nitrogen; CABG, coronary artery bypass graft; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CVA/TIA, cerebrovascular accident/transient ischemic attack; ICD, implantable cardiac defibrillator; MI, myocardial infarction; PCI, percutaneous coronary intervention; PVD, peripheral vascular disease; STEMI, ST‐segment elevation myocardial infarction; UTD, unable to determine.

Study Outcomes in AF Patients
-----------------------------

Overall all‐cause mortality at 1 year was 35.3% and the rate of all‐cause readmission or mortality at 1 year was 72.4%. There was a significant difference in mortality by 1 year across the tertiles (log rank *P*\<0.0001) ([Figure 3](#fig03){ref-type="fig"}). In contrast to the SR patients, the composite outcome of mortality/all‐cause readmission was not significantly different across the discharge heart rate tertiles ([Table 6](#tbl06){ref-type="table"}).

###### 

Frequency of 1‐Year Outcomes by Heart Rate Tertiles (Atrial Fibrillation Patients)

  Variable                             Level   Overall (N=20 197)   T1 (32 to 68 bpm) (N=6692)   T2 (69 to 79 bpm) (N=6385)   T3 (80 to 168 bpm) (N=7120)   *P* Value                          
  ------------------------------------ ------- -------------------- ---------------------------- ---------------------------- ----------------------------- ----------- ------- ------ ------- ----------
  Mortality                            Yes     7138                 35.34                        2161                         32.29                         2210        34.61   2767   38.86   \<0.0001
  All‐cause readmission                Yes     12 543               62.10                        4212                         62.94                         3976        62.27   4355   61.17   0.0940
  Mortality or all‐cause readmission   Yes     14 612               72.35                        4795                         71.65                         4596        71.98   5221   73.33   0.0649

![Kaplan--Meier plot of event‐free survival by 1 year in patients with atrial fibrillation (n=20 197). There was a significant difference across the discharge heart rate tertiles (log rank *P*\<0.0001), with survival highest in the lowest tertile (see text for details). BPM indicates beats per minute.](jah3-4-e001626-g3){#fig03}

Crude and adjusted measures of the association between discharge heart rate (expressed as a continuous variable) and each outcome are reported in [Table 7](#tbl07){ref-type="table"}. For patients with a discharge heart rate ≥75 bpm, there were worse outcomes with increasing heart rate. The slope of this relationship changed only slightly for patients with heart rate \<75 bpm ([Figure 4](#fig04){ref-type="fig"}). After adjustment for differences in clinical characteristics, the risk for all‐cause mortality increased, overall, by 8.4% (HR 1.084, 95% CI 1.039, 1.131; *P*=0.0002) per 10 bpm increase in heart rate for patients with discharge heart rate \<75 bpm and 8.8% (HR 1.088, 95% CI 1.056, 1.120; *P*\<0.0001) in patients with heart rate ≥75 bpm. There was a 22.8% (HR 1.228, 95% CI 1.165, 1.294; *P*\<0.0001) per 10 bpm increment in heart in rate for the first 30 days at heart rate ≥75 bpm. Beyond that, and through 365 days, the risk for all‐cause mortality was 4.9% higher (HR 1.049, 95% CI 1.014, 1.084; *P*=0.0053) for each 10‐beat increment. Of note is that for heart rate \<75 bpm, the risk for mortality increased by 8.7% (HR 1.087, 95% CI 1.042, 1.134; *P*=0.0024) per 10 bpm increment in heart rate. At heart rates \<75 bpm there was no significant association between heart rate and risk for all‐cause readmission or risk for the composite outcome of readmission/mortality. At heart rates ≥75 bpm, there was a 10.7% increase in risk (HR 1.107, 95% CI 1.073, 1.143; *P*\<0.0001) per 10‐beat increment for short‐term (0 to 30 days) all‐cause readmission and a 12.2% increased risk (HR 1.122, 95% CI 1.089, 1.155; *P*\<0.0001) per 10‐beat increment for the short‐term composite outcome readmission/mortality. This increase in risk for the latter outcomes was not, however, present at heart rates ≥75 bpm from 31 to 365 days ([Table 7](#tbl07){ref-type="table"}).

###### 

Hazard Ratios for Heart Rate, per 10 bpm (Atrial Fibrillation Patients, n=20 197)

  Outcome                                                Unadjusted Model   Adjusted Model (Patient and Hospital Characteristics)                                     
  ------------------------------------------------------ ------------------ ------------------------------------------------------- ---------- ------- -------------- ----------
  Mortality                                                                                                                                                           
  Heart rate \<75 bpm[\*](#tf7-1){ref-type="table-fn"}   1.074              1.033, 1.117                                            0.0003     1.084   1.039, 1.131   0.0002
  Heart rate \<75 bpm                                    1.083              1.041, 1.126                                            \<0.0001   1.087   1.042, 1.134   0.0001
  Heart rate ≥75 bpm[\*](#tf7-1){ref-type="table-fn"}    1.122              1.093, 1.151                                            \<0.0001   1.088   1.056, 1.120   \<0.0001
  Heart rate ≥75 bpm                                                                                                                                                  
  \[0, 30\] days                                         1.312              1.262, 1.364                                            \<0.0001   1.228   1.165, 1.294   \<0.0001
  \[31, 365\] days                                       1.043              1.011, 1.076                                            0.0082     1.049   1.014, 1.084   0.0053
  All‐cause readmission                                                                                                                                               
  Heart rate \<75 bpm[\*](#tf7-1){ref-type="table-fn"}   1.009              0.980, 1.038                                            0.5508     1.011   0.981, 1.041   0.4833
  Heart rate \<75 bpm                                    1.011              0.982, 1.040                                            0.4572     1.013   0.983, 1.043   0.4012
  Heart rate ≥75 bpm[\*](#tf7-1){ref-type="table-fn"}    1.026              1.004, 1.048                                            0.0224     1.033   1.010, 1.057   0.0046
  Heart rate ≥75 bpm                                                                                                                                                  
  \[0, 30\] days                                         1.094              1.062, 1.128                                            \<0.0001   1.107   1.073, 1.143   \<0.0001
  \[31, 365\] days                                       0.978              0.952, 1.006                                            0.1247     0.983   0.955, 1.012   0.2410
  Composite readmission/mortality                                                                                                                                     
  Heart rate \<75 bpm[\*](#tf7-1){ref-type="table-fn"}   1.008              0.982, 1.035                                            0.5531     1.012   0.984, 1.041   0.3902
  Heart rate \<75 bpm                                    1.012              0.985, 1.040                                            0.3812     1.015   0.986, 1.043   0.3167
  Heart rate ≥75 bpm[\*](#tf7-1){ref-type="table-fn"}    1.066              1.045, 1.086                                            \<0.0001   1.048   1.026, 1.071   \<0.0001
  Heart rate ≥75 bpm                                                                                                                                                  
  \[0, 30\] days                                         1.156              1.126, 1.186                                            \<0.0001   1.122   1.089, 1.155   \<0.0001
  \[31, 365\] days                                       0.996              0.970, 1.022                                            0.7336     0.998   0.972, 1.025   0.8917

bpm indicates beats per minute; HR, hazard ratio.

Ignoring violation of proportional hazards assumption (see text for details), model adjusted for the following covariates: age, gender, race (white vs other), insurance (none, Medicare, Medicaid, other), ejection fraction, history of atrial flutter, history of chronic obstructive pulmonary disease or asthma, history of diabetes, history of hyperlipidemia, history of hypertension, history of peripheral vascular disease, prior myocardial infarction, prior stroke or transient ischemic attack, history of anemia, history of chronic renal insufficiency, pacemaker, smoking, geographic region, academic or teaching hospital, rural location, hospital size, defect‐free compliance score.

![Estimated mortality at 1 year in patients with atrial fibrillation (n=20 197). The inflection point represents a single linear spline at 75 bpm (see text for details). Risk of mortality rises steadily with heart rate, although the slope of this relationship is less steep than the corresponding slope in sinus rhythm patients. BPM indicates beats per minute.](jah3-4-e001626-g4){#fig04}

There was no evidence of effect modification by CRT in the model for mortality (interaction *P*=0.619), and further adjusting for CRT status yielded mostly similar results as presented previously, although the HR for heart rates ≥75 bpm from 31 to 365 days was no longer significant (*P*=0.2945). There was evidence of effect modification by CRT in the models for all‐cause readmission (*P*=0.031) and composite readmission/mortality (*P*=0.033) ([Table 8](#tbl08){ref-type="table"}). The interaction term (heart rate×EF) was statistically significant in adjusted models for mortality (interaction *P*=0.010), all‐cause readmission (*P*=0.003), and composite readmission/mortality (*P*=0.019). The association between heart rate and mortality was more pronounced among patients with EF \>0.40 compared to EF ≤0.40 (interaction *P*=0.010). Further evidence of effect modification was observed for all‐cause readmission and composite all‐cause mortality/readmission outcomes (interaction *P*=0.003, *P*=0.019, respectively) ([Table 9](#tbl09){ref-type="table"}).

###### 

Hazard Ratios (HR) for Heart Rate, per 10 bpm Increase (Atrial Fibrillation Patients, n=20 197)

  Outcome                           Unadjusted Model   Adjusted Model                                     
  --------------------------------- ------------------ ---------------- ---------- ------- -------------- ----------
  All‐cause readmission                                                                                   
  No CRT                                                                                                  
  Heart rate \<75 bpm               1.001              0.959, 1.046     0.9509     1.008   0.963, 1.055   0.7312
  Heart rate ≥75 bpm                                                                                      
  \[0, 30\] days                    1.079              1.030, 1.130     0.0013     1.094   1.043, 1.147   0.0002
  \[31, 365\] days                  0.962              0.921, 1.004     0.0762     0.969   0.927, 1.013   0.1693
  CRT                                                                                                     
  Heart rate \<75 bpm               1.072              0.928, 1.239     0.3434     1.071   0.924, 1.242   0.3614
  Heart rate ≥75 bpm                                                                                      
  \[0, 30\] days                    1.342              1.169, 1.541     \<0.0001   1.297   1.120, 1.502   0.0005
  \[31, 365\] days                  0.909              0.762, 1.085     0.2910     0.880   0.736, 1.052   0.1608
  Composite readmission/mortality                                                                         
  No CRT                                                                                                  
  Heart rate \<75 bpm               1.010              0.970, 1.053     0.6211     1.015   0.972, 1.059   0.5070
  Heart rate ≥75 bpm                                                                                      
  \[0, 30\] days                    1.118              1.073, 1.165     \<0.0001   1.098   1.050, 1.148   \<0.0001
  \[31, 365\] days                  0.979              0.940, 1.019     0.2889     0.987   0.946, 1.028   0.5231
  CRT                                                                                                     
  Heart rate \<75 bpm               1.102              0.960, 1.266     0.1665     1.091   0.946, 1.260   0.2324
  Heart rate ≥75 bpm                                                                                      
  \[0, 30\] days                    1.312              1.150, 1.497     \<0.0001   1.282   1.112, 1.478   0.0006
  \[31, 365\] days                  0.918              0.778, 1.083     0.3101     0.898   0.760, 1.061   0.2044

bmp indicates beats per minute; CRT, cardiac resynchronization therapy.

###### 

Hazard Ratios (HR) for Heart Rate, per 10 bpm Increase (Atrial Fibrillation Patients, n=20 197)

  Outcome                           Unadjusted Model   Adjusted Model                                     
  --------------------------------- ------------------ ---------------- ---------- ------- -------------- ----------
  Mortality                                                                                               
  LVEF ≤40%                                                                                               
  Heart rate \<75 bpm               1.050              0.988, 1.117     0.1178     1.048   0.980, 1.120   0.1703
  Heart rate ≥75 bpm                                                                                      
  \[0, 30\] days                    1.311              1.240, 1.387     \<0.0001   1.220   1.130, 1.316   \<0.0001
  \[31, 365\] days                  0.991              0.943, 1.041     0.7090     1.005   0.953, 1.059   0.8634
  LVEF \>40%                                                                                              
  Heart rate \<75 bpm               1.101              1.046, 1.159     0.0002     1.117   1.057, 1.180   \<0.0001
  Heart rate ≥75 bpm                                                                                      
  \[0, 30\] days                    1.315              1.252, 1.380     \<0.0001   1.234   1.156, 1.316   \<0.0001
  \[31, 365\] days                  1.082              1.040, 1.125     \<0.0001   1.080   1.035, 1.126   0.0004
  All‐cause readmission                                                                                   
  LVEF ≤40%                                                                                               
  Heart rate \<75 bpm               1.010              0.964, 1.058     0.6845     1.008   0.960, 1.057   0.7588
  Heart rate ≥75 bpm                                                                                      
  \[0, 30\] days                    1.115              1.067, 1.165     \<0.0001   1.127   1.076, 1.180   \<0.0001
  \[31, 365\] days                  0.933              0.892, 0.976     0.0023     0.931   0.889, 0.975   0.0024
  LVEF \>40%                                                                                              
  Heart rate \<75 bpm               1.011              0.975, 1.049     0.5601     1.017   0.980, 1.056   0.3806
  Heart rate ≥75 bpm                                                                                      
  \[0, 30\] days                    1.081              1.039, 1.123     \<0.0001   1.094   1.051, 1.139   \<0.0001
  \[31, 365\] days                  1.009              0.975, 1.044     0.6187     1.018   0.982, 1.055   0.3289
  Composite readmission/mortality                                                                         
  LVEF ≤40%                                                                                               
  Heart rate \<75 bpm               1.009              0.967, 1.053     0.6788     1.006   0.962, 1.053   0.7826
  Heart rate ≥75 bpm                                                                                      
  \[0, 30\] days                    1.172              1.129, 1.217     \<0.0001   1.141   1.093, 1.191   \<0.0001
  \[31, 365\] days                  0.946              0.908, 0.985     0.0075     0.950   0.910, 0.991   0.0183
  LVEF \>40%                                                                                              
  Heart rate \<75 bpm               1.012              0.978, 1.047     0.4974     1.021   0.985, 1.058   0.2575
  Heart rate ≥75 bpm                                                                                      
  \[0, 30\] days                    1.145              1.108, 1.183     \<0.0001   1.108   1.067, 1.150   \<0.0001
  \[31, 365\] days                  1.030              0.997, 1.063     0.0729     1.031   0.997, 1.066   0.0707

bmp indicates beats per minute; LVEF, left ventricular ejection fraction.

EF data were missing in 4.70% of AF patients. There was no significant interaction between heart rate and the presence or absence of missing EF data (*P* for interaction 0.81), indicating no difference in the degree of association between heart rate and all‐cause mortality between those with missing and nonmissing EF data.

Discussion
==========

In this analysis of over 46 000 patients discharged alive following treatment for HF in centers participating in the AHA GWTG‐HF program from 2005 to 2011, we observed a significant and independent association of heart rate at the time of discharge on the risks for short‐ (discharge to 30 days) and longer‐term (31 to 365 days) mortality in SR and AF patients. The associations between discharge heart rate and risks of all‐cause readmission and the composite outcome of all‐cause mortality/readmission were significant over the short term in both SR and AF, but only for the composite outcome over the longer term in SR. The magnitude of the association (HR) was greater over the short term and varied according to the cardiac rhythm status. Among patients with AF, the magnitude of association was significantly modified by discharge CRT status (all‐cause readmission and the composite outcome) and by EF (all outcomes).

Our data are in qualitative agreement with conclusions from prior studies regarding an overall positive association between heart rate and adverse cardiovascular outcomes in patients with HF ([Table 10](#tbl10){ref-type="table"}). However, important differences exist. Studies derived from randomized clinical trials of specific therapies and which analyzed "baseline" (prerandomization) heart rate as the covariate of interest have been inconsistent in identifying a clinically meaningful association with postdischarge adverse outcomes.^[@b5]--[@b7]^ Clinical trials that narrowed heart rate inclusion criteria^[@b4]^ or studies in which post‐hoc defined cut points for the analysis of the heart rate--outcome association^[@b3],[@b6]^ were employed differ methodologically from the present study and enrolled more selective patient populations. Most prior studies excluded patients with AF. Few studies included patients with HF and preserved EF. The majority of prior studies also failed to take into account, or report, the extent of guideline‐based medical and device therapy. Finally, no study recognized, or reported, a time‐dependence of the heart‐rate‐outcome association.

###### 

Summary of Recent Clinical Trial and Population‐Based Studies of the Association Between Heart Rate and Clinical Outcomes in Patients With and Without Prevalent HF

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study (Ref)                      Year   Study Design/Patient Population                                                       Specific Outcome(s)                       Estimate of Magnitude of Association                              Atrial Fibrillation Included?
  -------------------------------- ------ ------------------------------------------------------------------------------------- ----------------------------------------- ----------------------------------------------------------------- -------------------------------
  BEAUTIFUL^[@b3]^                 2008   RCT/CAD,LVD, heart rate ≥60 bpm                                                       CV death\                                 Post‐Rx HR 1.08 per 5 bpm\                                        No
                                                                                                                                HF admission                              Post‐Rx HR 1.16 per 10 bpm                                        

  SHIFT^[@b4]^                     2010   RCT/HFrEF, heart rate ≥70 bpm                                                         Composite (CV death/hospital admission)   Post‐Rx HR 1.16 per 5 bpm                                         No

  CHARM^[@b5]^                     2012   RCT/HFrEF, HFpEF                                                                      All‐cause mortality                       "pre‐Rx" HR 1.06 per 10 bpm                                       Yes

  EVEREST^[@b6]^                   2013   RCT/HFrEF                                                                             All‐cause mortality                       "baseline" HR 1.05 per 5 bpm[\*](#tf10-1){ref-type="table-fn"}\   No
                                                                                                                                                                          "discharge" HR 1.20 per 5 bpm[\*](#tf10-2){ref-type="table-fn"}   

  Kapoor and Heidenreich^[@b18]^   2010   Prospective cohort/HFpEF                                                              All‐cause mortality                       HR 1.47 for heart rate 70 to 90 (compared to rate \<60)           No

  AHA GWTG‐HF^[@b19]^              2013   Prospective, registry design/HFrEF, HFpEF/in‐patient                                  In‐hospital mortality                     Admission HR 1.20 per 10 bpm                                      Yes

  FRAMINGHAM^[@b20]^               2014   Prospective cohort, population‐based/no prevalent CV disease                          All‐cause mortality                       HR 1.17 per 11 bpm                                                No

  MESA^[@b21]^                     2014   Prospective cohort, population‐based/no prevalent CV disease                          Incident HF                               HR 1.04 per 1 bpm                                                 No

  EFFECT‐HF^[@b7]^                 2014   Retrospective, population‐based, observational/post‐hospital discharge/HFrEF, HFpEF   All‐cause mortality                       OR 1.41 for heart rate \>90 (compared to heart rate 40 to 60)     No

  Cullington, et al^[@b22]^        2014   Retrospective/prospective, community‐based, observational/HFrEF                       All‐cause mortality                       HR 1.10 per 10 bpm for SR patients only                           Yes

  Present study\                   2014   Prospective, registry design/HFrEF, HFpEF/post‐hospital discharge                     All‐cause mortality\                      See Results                                                       Yes
  AHA GWTG‐HF                                                                                                                   All‐cause mortality/readmission                                                                             
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

bpm indicates beats per minute; CAD, coronary artery disease; CV, cardiovascular; HF, heart failure; HR, hazard ratio; LVD, left ventricular dysfunction; OR, odds ratio; pEF, preserved ejection fraction; RCT, randomized clinical trial; rEF, reduced ejection fraction; SR, sinus rhythm.

*P*=0.066, heart rate ≥70 bpm.

*P*\<0.001, heart rate ≥70 bpm.

A prior study from the GWTG‐HF program identified an association between the admission heart rate and in‐hospital mortality.^[@b19]^ Although the magnitude of the association in that study depended on the cardiac rhythm, the EF, and the absolute heart rate, there was, overall, a 23% increase in the adjusted odds of in‐hospital death per 10‐bpm increment in heart rate.^[@b19]^ Differences between these 2 studies derive from a number of considerations. First, the latter study analyzed admission heart rate as the covariate of interest, whereas the current study analyzed discharge heart rate and, as such, an association between discharge heart rate and outcome will reflect the impact of treatment and the nature of the association will quite likely differ. Second, the latter study reported crude in‐hospital mortality rates, whereas the current study reports the predicted probability of mortality obtained from the adjusted Cox multivariable model. Adjusted probabilities will likely differ from unadjusted crude rates. Third, the "plateau" in the curve for AF patients in the latter study appears outside of the 5% to 95% percentile distribution of heart rates and may reflect the paucity of data in this region, suggesting limited precision of an estimate. However, both studies agree in that mortality in AF patients exceeds that for SR patients for any heart rate. Finally, "flattening" of the association between heart rate and mortality in AF patients relative to SR patients in both the inpatient study and the present outpatient study are congruent observations.

In the present report from the GWTG‐HF program, we extended the analysis to specifically examine the impact of the heart rate at the time of discharge on longer‐term outcomes. The heart rate at the time of discharge is more likely to reflect the totality of the in‐hospital treatment program including the extent of use of guideline‐based therapies including β‐blockers. Indeed, the average discharge heart rate was lower than that on admission, consistent with such treatment. By including the defect‐free care measure in our adjusted analysis (and thereby accounting for differences in β‐blocker use across the tertiles of heart rate), our findings not only differ from prior studies in this regard but also underscore the powerful, independent, and persistent effect of heart rate on longer‐term outcomes.

In patients with AF, although early (0 to 30 days) and late (31 to 365 days) associations between heart rate and mortality were statistically significant at rates ≥75 bpm, the magnitude of this association decreased over the late term, mirroring the change in HR over time in SR patients. In contrast to the findings in patients in SR, the HRs for the association between discharge heart rate and all‐cause readmission and the composite outcome were not statistically significant and suggest that in patients with AF, heart rate might be of lesser importance over the long term.^[@b22]^ It should be recalled that patients with HF and AF are at intrinsically higher risk for death or readmission compared with patients in SR.^[@b12]--[@b13]^ The decreased slope of the overall heart‐rate‐outcome relationship in patients with AF compared to patients with SR may reflect this increased baseline risk in patients with AF, which effectively attenuates a "heart rate" effect. Nevertheless, 50% of the patients in AF had a discharge HR \>74 bpm, suggesting additional opportunity for potential benefit of further rate control on outcome.

We identified an early phase (0 to 30 days) HR and a later phase (31 to 365 days) HR for patients with either SR or AF. The HR for the association between heart rate and mortality between 0 and 30 days (early phase) and from 31 to 365 days (later phase) was numerically higher for SR patients compared to AF patients. In addition, in both groups of patients the magnitude of this association diminished over the interval from 31 to 365 days. These findings suggest that there may be potential early postdischarge benefit from lowering heart rate in patients hospitalized with HF in addition to benefit from decreasing the heart rate over the longer term.^[@b4]^ In the present study, 25% of the patients in SR had a discharge heart rate \<64 bpm and would likely not be candidates for aggressive attempts at further rate reduction. However, for the 50% of SR patients with a discharge heart rate \>72 bpm, further efforts toward rate reduction during this critical time window might be of benefit.

Speculation regarding a fundamental pathophysiologic relationship between higher heart rate and the development^[@b20]--[@b21]^ or worsening of HF^[@b8]--[@b10]^ has ranged from myocardial energetic considerations^[@b23]^ to favorable alterations in arterial afterload with heart rate reduction.^[@b24]^ By targeting heart rate as a potentially modifiable risk factor in the progression of HF, the SHIFT trial^[@b4]^ has implicated heart rate in the causal pathway of HF progression. Whether benefit from heart rate reduction derives from reduced myocardial oxygen consumption and improved myocardial efficiency, reduced total afterload, or alternative explanations^[@b25]^ remains to be determined.

The present study has a number of limitations that merit discussion. This is a retrospective analysis from a prospectively designed and conducted registry. Data were collected by chart review and are, therefore, dependent on the quality and accuracy of data collection. Hospitals voluntarily participating in GWTG‐HF may not be representative of all hospitals in the United States, although prior study has shown that GWTG‐HF patients and hospitals have characteristics similar to hospitals nationwide. We restricted the analysis to fee‐for‐service Medicare beneficiaries ≥65 years of age in order to allow for assessment of postdischarge outcomes by linkage of GWTG‐HF records with those from Medicare. However, the majority of patients hospitalized with HF in the United States are over the age of 65 years.^[@b26]^ Characteristics and outcomes of Medicare beneficiaries in previous HF registries were similar to the broader Medicare population with HF, suggesting that findings from such registries may be generalizable.^[@b27]^ The extent of missing biomarker data (eg, N‐terminal pro‐brain natriuretic peptide, brain natriuretic peptide) in this registry precludes more objective measures of disease severity. This study was not a prospective randomized trial, and residual measured and unmeasured confounders might have influenced reported outcomes notwithstanding extensive statistical adjusting of the crude rates. Although other medications potentially affecting heart rate (eg, calcium channel blockers, digoxin, amiodarone, and β‐agonists in patients with COPD) are used in patients with HF, these medications are not systematically tracked in this quality assurance program. Consequently, the current models cannot adjust for their use. Attention is drawn, however, to the \>90% prevalence of β‐blockers and their dominant effect on heart rate at discharge. This registry does not record provider intention with respect to the management of AF (rate versus rhythm control). Therefore, selection bias and residual confounding due to the use of β‐blockers for rate control in patients with HF and AF is another limitation. As noted above, overall β‐blocker use in AF patients exceeded 90%. The study is also limited in the absence of cause‐specific outcomes. In the absence of independent clinical outcome assessment as would be the case in a clinical trial, we suggest that our choices for all‐cause mortality and all‐cause hospitalization are less subject to bias (eg, misclassification bias), which often limits inferences from observational studies. Increased sensitivity using an all‐cause outcome allows for identification of clinical outcomes in these older subjects that are of broad clinical relevance. We believe that these considerations do not detract from our conclusions regarding the adverse effect of increased heart rate in patients with HF even after accounting for the extent of guideline‐directed medical therapy.

In summary, our observations add to the growing evidence base for a positive association between heart rate and adverse clinical outcomes in patients with HF. Our findings expand on these prior observations and indicate a biphasic nature to the time‐dependent hazard with an early (0 to 30 day) substantial increase in the HR for mortality and a longer‐term (31 to 365 days) lower, albeit persistently and significantly increased, HR. These observations suggest additional opportunities to improve outcomes for HF patients in SR or AF, patients with preserved or depressed left ventricular systolic function, and patients with persistently increased heart rate at the time of hospital discharge.
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